ATAC DDC Liaisons: Orlando Roman and Fred Schaich
CONTACT INFORMATION
Mike Nelson
Director, Patient Relations/Virology
Public Affairs
Roche
973-562-2409 (phone)
973-235-3337 (fax)
[email protected]
PRODUCT INFORMATION
- FDA-Approved Products:
- Nucleoside analogue reverse transcriptase inhibitor:
- zalcitabine (Hivid®, ddC, dideoxycytidine) - virtually not used any more
- Protease inhibitor: saquinavir (two formulations: hard gel cap Invirase®, soft gel cap Fortovase®)
- Fusion inhibitor: enfuvirtide (Fuzeon, T-20)
- Products in Clinical Trials:
Web pages:
|